Cloning and expression of human mitogen-activated protein kinase kinase 7gamma1

Laura Michael1, Jennifer Swantek, Megan J Robinson

  • 1Pfizer Global Research & Development, Michigan Laboratories, Department of Inflammation Biology, Ann Arbor, USA. Laura.Michael@Pfizer.com

Insights

Researchers cloned human MKK7gamma1, a key activator of c-Jun N-terminal kinase (JNK). This MKK7 isoform is expressed in various human tissues, tumors, and synoviocytes, suggesting a role in cellular signaling and disease.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Mitogen-activated protein kinase kinase 7 (MKK7) is a critical activator of c-Jun N-terminal kinase (JNK).
  • MKK7 activates JNK through phosphorylation of specific residues within kinase subdomain VIII.
  • While six murine MKK7 isoforms are known, only three human isoforms have been reported.

Purpose of the Study:

  • To report the cloning of hMKK7gamma1, the human homolog of murine MKK7gamma1.
  • To investigate the expression patterns of hMKK7gamma1 in various human tissues and disease states.
  • To assess the activation potential of recombinant hMKK7gamma1.

Main Methods:

  • Cloning of the human MKK7gamma1 gene.
  • Messenger RNA (mRNA) expression analysis using PCR in various tissues, tumors, and synoviocytes.
  • In vitro phosphorylation and activation assays using recombinant hMKK7gamma1 and MEKK1.

Main Results:

  • The human MKK7gamma1 gene was successfully cloned.
  • hMKK7gamma1 mRNA transcripts were detected in placenta, fetal liver, and skeletal muscle.
  • Expression was also observed in diverse normal tissues, tumors, and synoviocytes from patients with rheumatoid and osteoarthritis.

Conclusions:

  • hMKK7gamma1 is a newly identified human MKK7 isoform.
  • Its expression in various tissues and disease-associated cells suggests a significant role in human physiology and pathology.
  • Recombinant hMKK7gamma1 can be activated by MEKK1, providing a basis for further functional studies.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...